Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA13010024 1-(O-alpha-D-galactopyranosyl)-3-keto-(1,27R,29R)-triacontanetriol 1-(O-alpha-D-galactopyranosyl)-3-keto-(1,27R,29R)-triacontanetriol C36H70O9 646.501986
LMFA13010025 1-(O-alpha-D-glucopyranosyl)-(1,3S,25R)-hexacosanetriol 1-(O-alpha-D-glucopyranosyl)-(1,3S,25R)-hexacosanetriol C32H64O8 576.460121
LMFA13010026 1-(O-alpha-D-glucopyranosyl)-(1,3S,27R)-octacosanetriol 1-(O-alpha-D-glucopyranosyl)-(1,3S,27R)-octacosanetriol C34H68O8 604.491421
LMFA13010027 1-(O-alpha-D-glucopyranosyl)-25-keto-(1,3R,27R)-octacosanetriol 1-(O-alpha-D-glucopyranosyl)-25-keto-(1,3R,27R)-octacosanetriol C34H66O9 618.470686
LMFA13010028 1-(O-alpha-D-mannopyranosyl)-25-keto-(1,3R,27R)-octacosanetriol 1-(O-alpha-D-mannopyranosyl)-25-keto-(1,3R,27R)-octacosanetriol C34H66O9 618.470686
LMFA13010029 1-(O-alpha-D-glucopyranosyl)-27-keto-(1,3R,29R)-triacontanetriol 1-(O-alpha-D-glucopyranosyl)-27-keto-(1,3R,29R)-triacontanetriol C36H70O9 646.501986
LMFA13010030 1-(O-alpha-D-glucopyranosyl)-29-keto-(1,3R,31R)-dotriacontanetriol 1-(O-alpha-D-glucopyranosyl)-29-keto-(1,3R,31R)-dotriacontanetriol C38H74O9 674.533286
LMFA13010031 1-(O-alpha-D-mannopyranosyl)-29-keto-(1,3R,31R)-dotriacontanetriol 1-(O-alpha-D-mannopyranosyl)-29-keto-(1,3R,31R)-dotriacontanetriol C38H74O9 674.533286
LMFA03010000 Prostanoic acid skeleton FA 20:1 C20H38O2 310.287181
LMFA03030000 Thromboxanoic acid skeleton
LMFA11000009 5,13,16-trimethyloctacosane 5,13,16-trimethyloctacosane C31H64 436.500801
LMFA11000010 1-(3-methylpentadecyl)-3-nonylcyclopentane 1-(3-methylpentadecyl)-3-nonylcyclopentane C30H60 420.469501
LMFA11000011 3,7,11,15,18-pentamethyloctacosane 3,7,11,15,18-pentamethyloctacosane C33H68 464.532101
LMFA03010194 Prostaglandin M 7R-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid FA 16:4;O5 C16H24O7 328.152205
LMFA03010195 Dihomo-PGI2 6,9S-epoxy-11R,15S-dihydoxy-5Z,13E-1a,1b-dihomo-prostadienoic acid FA 22:4;O3 C22H36O5 380.256276
LMFA04010010 7-epi-14-F4t-NeuroP 8S,10R,14S-trihydroxy-4Z,12E,16Z,19Z-neuroprostatetraenoic acid-cyclo[7R,11R] FA 22:5;O3 C22H34O5 378.240626
LMFA03010196 PGF2alpha-1,9-lactone 11R,15S-dihydroxy-5Z,13E-prostadienoic acid-1,9S-lactone FA 20:4;O2 C20H32O4 336.230061
LMFA03010197 PGF3alpha-1,15-lactone 9S,11R-dihydroxy-5Z,13E,17Z-prostatrienoic acid-1,15S-lactone FA 20:5;O2 C20H30O4 334.214411
LMFA03010198 PGE2 1,15-lactone 9-oxo-11R-hydroxy-5Z,13E-prostadienoic acid-1,15S-lactone FA 20:5;O2 C20H30O4 334.214411
LMFA03010199 PGE3 1,15-lactone 9-oxo-11R-hydroxy-5Z,13E,17Z-prostatrienoic acid-1,15S-lactone FA 20:6;O2 C20H28O4 332.198761
LMFA03010200 PGA2 1,15-lactone 9-oxo-5Z,10,13E-prostatrienoic acid-1,15S-lactone FA 20:6;O C20H28O3 316.203846
LMFA03010201 15R-PGE2 methyl ester, 15-acetate methyl 9-oxo-11R-hydroxy-15R-acetoxy-5Z,13E-prostadienoate FA 23:5;O4 C23H36O6 408.251191
LMFA03010202 15R-PGA2 methyl ester, 15-acetate methyl 9-oxo-11R-hydroxy-15R-acetoxy-5Z,10,13E-prostatrienoate FA 23:6;O3 C23H34O5 390.240626
LMFA03110011 (+/-) 5-iPF2alpha-VI 5,9S,11R-trihydroxy-6E,14Z-prostadienoic acid-cyclo[8S,12R] FA 20:3;O3 C20H34O5 354.240626
LMFA03110012 (+/-) 5-iPF2alpha-VI-(d11) 5,9S,11R-trihydroxy-6E,14Z-prostadienoic acid-cyclo[8S,12R]-(d11) C20H23D11O5 365.309670
LMFA03020031 14,15-LTC4 15S-hydroxy-14R-(S-glutathionyl)-5Z,8Z,10E,12E-eicosatetraenoic acid C30H47N3O9S 625.303303
LMFA03020032 14,15-LTD4 15S-hydroxy,14R-(S-cysteinylglycinyl)-5Z,8Z,10E,12E-eicosatetraenoic acid C25H40N2O6S 496.260709
LMFA03010203 11beta-13,14-dihydro-15-keto PGF2alpha 9S,11R-dihydroxy-15-oxo-5Z-prostenoic acid FA 20:3;O3 C20H34O5 354.240626
LMFA03040003 epi-Lipoxin A4 5S,6S,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA03020033 14,15-LTE4 15S-hydroxy-14R-(S-cysteinyl)-5Z,8Z,10E,12E-eicosatetraenoic acid C23H37NO5S 439.239245
LMFA04040003 Protectin DX 10S,17S-dihydroxy-4Z,7Z,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230061
LMFA02000234 12,13 diHOME-(d4) 12,13-dihydroxy-9Z-octadecenoic acid-(d4) C18H30D4O4 318.270818
LMFA02000235 9,10-diHOME-(d4) 9,10-dihydroxy-12Z-octadecenoic acid-(d4) C18H30D4O4 318.270818
LMFA02000236 13S-HODE-(d4) 13S-hydroxy-9Z,11E-octadecadienoic acid-(d4) C18H28D4O3 300.260252
LMFA03050020 (+/-)14,15-EpETrE-(d8) 14,15-epoxy-5Z,8Z,11Z-eicosatrienoic acid-(d8) C20H24D8O3 328.285359
LMFA03050021 (+/-)8,9-EpETrE-(d8) 8,9-epoxy-5Z,11Z,14Z-eicosatrienoic acid-(d8) C20H24D8O3 328.285359
LMFA01030763 Oleic acid (d5) 9Z-octadecenoic acid (d5) C18H29D5O2 287.287264
LMFA04050001 Maresin 1 7R,14S-dihydroxy-4Z,8E,10E,12Z,16Z,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230061
LMFA08020074 N-arachidonoyl GABA N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-gamma-aminobutyric acid NA 24:5;O2 C24H39NO3 389.292994
LMFA08020075 N-arachidonoyl taurine N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-taurine NAT 20:4 C22H37NO4S 411.244330
LMFA08020077 N-stearoyl glycine N-octadecanoyl-glycine NA 20:1;O2 C20H39NO3 341.292994
LMFA08020078 N-stearoyl taurine N-octadecanoyl-taurine NAT 18:0 C20H41NO4S 391.275630
LMFA08020080 N-palmitoyl taurine N-hexadecanoyl-taurine NAT 16:0 C18H37NO4S 363.244330
LMFA08020081 N-oleoyl taurine N-(9Z-octadecenoyl)-taurine C20H39NO4S 389.259980
LMFA08020083 N-docosanoyl taurine N-docosanoyl-taurine NAT 22:0 C24H49NO4S 447.338230
LMFA06000114 2-chloropalmitaldehyde 2-chlorohexadecanal C16H31OCl 274.206344
LMFA08020076 N-arachidonoyl tyrosine N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-tyrosine NATyr 20:4 C29H41NO4 467.303559
LMFA08020082 N-oleoyl glycine N-(9Z-octadecenoyl)-glycine NAGly 18:1 C20H37NO3 339.277344
LMFA08020073 N-arachidonoyl L-serine N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-L-serine NASer 20:4 C23H37NO4 391.272259
LMFA05000084 3,7,11,15,18,22,26,30-octamethyldotriacontane-1,32-diol 3R,7R,11R,15S,18S,22R,26R,30R-octamethyldotriacontane-1,32-diol FOH 40:0;O C40H82O2 594.631481